@techcrunch.com 7 years ago
Sean Parker’s cancer institute may have found a blood test to find out if patients will respond to treatment
@techcrunch.com 7 years ago
CRISPR-Cas9 inventor Jennifer Doudna’s plans on moving forward, genetically modifying humans
@techcrunch.com 7 years ago
Oral arguments for who owns CRISPR-Cas9 starts next month
@techcrunch.com 9 years ago
StartX And QB3 Open A Biotech Lab In Palo Alto